Publications by authors named "Hastings Suba Ozwara"
J Infect Dev Ctries
June 2016
Article Synopsis
- Chemotherapy remains the primary method for controlling malaria in sub-Saharan Africa, with the use of artemether-lumefantrine increasing the risk of drug resistance to lumefantrine.
- Methylene blue has shown potential as an antimalarial candidate due to its effectiveness against drug-resistant strains of Plasmodium berghei in mice.
- The study found that a dosage of 45 mg/kg/day of methylene blue resulted in over 99% parasite inhibition for at least six days, indicating its promising role in developing treatments for resistant malaria strains without serious side effects.
